(Q57272633)
Statements
Class III beta-tubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer: analysis of NCIC JBR.10 (English)
Pascal Sève
Raymond Lai
Keyue Ding
Timothy Winton
Charles Butts
Laith Dabbagh
Sarit Aviel-Ronen
Lesley Seymour
Marlo Whitehead
Frances A Shepherd
1 February 2007